Details for Patent: 10,124,014

Which drugs does patent 10,124,014 protect, and when does it expire?

Patent 10,124,014 protects NUZYRA and is included in two NDAs.

This patent has eleven patent family members in eleven countries.

Summary for Patent: 10,124,014

Title:	Minocycline compounds and methods of use thereof
Abstract:	Methods and compositions for using a tetracycline compound to treat bacterial infections are described. In one embodiment, for example, the invention provides a method of treating a subject for an infection, comprising administering to said subject an effective amount of 9-[(2,2-dimethyl-propyl amino)-methyl]-minocycline or a salt thereof, such that said subject is treated, wherein said infection is selected from the group consisting of MSSA, MRSA, B-streptococci, Viridans Streptococci, Enterococcus, or combinations thereof.
Inventor(s):	Johnston; Sean M. (Doylestown, PA), Arbeit; Robert D. (W. Newton, MA), Bigger; Thomas J. (Norwell, MA), Molnar; Dennis P. (Hopkinton, MA), Tanaka; S. Ken (Needham, MA)
Assignee:	Paratek Pharmaceuticals, Inc. (Boston, MA)
Application Number:	15/637,144
Patent Claim Types: see list of patent claims	Use; Delivery; Dosage form;

Drugs Protected by US Patent 10,124,014

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Paratek Pharms Inc	NUZYRA	omadacycline tosylate	POWDER;INTRAVENOUS	209817-001	Oct 2, 2018		RX	Yes	Yes						TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTION
Paratek Pharms Inc	NUZYRA	omadacycline tosylate	TABLET;ORAL	209816-001	Oct 2, 2018		RX	Yes	Yes						TREATMENT OF BACTERIAL SKIN AND SKIN STRUCTURE INFECTION

International Family Members for US Patent 10,124,014

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2009220171
Brazil	PI0908951
Canada	2717703